NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit (Q74637316)
Jump to navigation
Jump to search
scientific article published on 01 August 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit |
scientific article published on 01 August 2002 |
Statements
NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit (English)